Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05801380
Status:
RECRUITING
Last Update Posted:
2023-04-06
First Post:
2023-03-10
Brief Title:
Monitoring Drug Efficacy in Patients With Alzheimers Disease
Sponsor:
University of the Philippines
Organization:
University of the Philippines
Study Overview
Official Title:
Monitoring Drug Efficacy Through Multi-omics Research Initiative in Alzheimers Disease
Status:
RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MEMORI-AD
Brief Summary:
This study will explore the different factors associated with drug response to acetylcholinesterase AChE inhibitor donepezil and NMDA receptor antagonist memantine in patients with Alzheimers Disease
Detailed Description:
These patients will be grouped according to the medications prescribed by their attending physician at baseline 3rd month and 6th month of follow up
1 Alzheimers Disease patients given AChE inhibitor monotherapy
2 Alzheimers Disease patients given combination therapy of AChE inhibitor and NMDA receptor antagonist
They will be observed for treatment response for up to 6 months
1 Alzheimers Disease patients given AChE inhibitor monotherapy
2 Alzheimers Disease patients given combination therapy of AChE inhibitor and NMDA receptor antagonist
They will be observed for treatment response for up to 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None